USB484068I5 - - Google Patents

Info

Publication number
USB484068I5
USB484068I5 US48406874A USB484068I5 US B484068 I5 USB484068 I5 US B484068I5 US 48406874 A US48406874 A US 48406874A US B484068 I5 USB484068 I5 US B484068I5
Authority
US
United States
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2207421A external-priority patent/DE2207421C3/de
Application filed filed Critical
Priority to US05/484,068 priority Critical patent/US3994937A/en
Publication of USB484068I5 publication Critical patent/USB484068I5/en
Application granted granted Critical
Publication of US3994937A publication Critical patent/US3994937A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
US05/484,068 1972-02-11 1974-06-28 15α,16α-Methylene-4-estren-17β-ols Expired - Lifetime US3994937A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US05/484,068 US3994937A (en) 1972-02-11 1974-06-28 15α,16α-Methylene-4-estren-17β-ols

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DT2207421 1972-02-11
DE2207421A DE2207421C3 (de) 1972-02-11 1972-02-11 15α, 16α -Methylen-4-östren-17β -ole bzw. -acylate, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
US33105973A 1973-02-09 1973-02-09
US05/484,068 US3994937A (en) 1972-02-11 1974-06-28 15α,16α-Methylene-4-estren-17β-ols

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US33105973A Continuation 1972-02-11 1973-02-09

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US05/891,456 Continuation US4264771A (en) 1973-07-19 1978-03-29 Alkylation of substituted oxazolinone-(5) compounds

Publications (2)

Publication Number Publication Date
USB484068I5 true USB484068I5 (da) 1976-03-02
US3994937A US3994937A (en) 1976-11-30

Family

ID=27184113

Family Applications (1)

Application Number Title Priority Date Filing Date
US05/484,068 Expired - Lifetime US3994937A (en) 1972-02-11 1974-06-28 15α,16α-Methylene-4-estren-17β-ols

Country Status (1)

Country Link
US (1) US3994937A (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007027636A1 (de) * 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-18a-homo-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3275666A (en) * 1963-03-13 1966-09-27 Organon 16-methylene steroids of the esterne series
US3469008A (en) * 1966-04-02 1969-09-23 Schering Ag Medicinal compositions which contain 15,16beta-methylene steroids of the 19 nor-androstane series
US3470160A (en) * 1966-04-02 1969-09-30 Schering Ag 15,16 beta-methylene steroids of the estrane and androstane series and methods for preparing same
US3525757A (en) * 1967-02-09 1970-08-25 Schering Ag Methods of preparing 15,16beta-methylene-testosterone and esters thereof
US3749742A (en) * 1971-02-24 1973-07-31 Schering Ag 15alpha,16alpha-methylene steroids and processes for their production and use

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3275666A (en) * 1963-03-13 1966-09-27 Organon 16-methylene steroids of the esterne series
US3469008A (en) * 1966-04-02 1969-09-23 Schering Ag Medicinal compositions which contain 15,16beta-methylene steroids of the 19 nor-androstane series
US3470160A (en) * 1966-04-02 1969-09-30 Schering Ag 15,16 beta-methylene steroids of the estrane and androstane series and methods for preparing same
US3525757A (en) * 1967-02-09 1970-08-25 Schering Ag Methods of preparing 15,16beta-methylene-testosterone and esters thereof
US3749742A (en) * 1971-02-24 1973-07-31 Schering Ag 15alpha,16alpha-methylene steroids and processes for their production and use

Also Published As

Publication number Publication date
US3994937A (en) 1976-11-30

Similar Documents

Publication Publication Date Title
JPS4952561U (da)
CS156810B1 (da)
CS155644B1 (da)
CS157982B1 (da)
CS157388B1 (da)
CS157348B1 (da)
CS157286B1 (da)
CS158027B1 (da)
JPS4981439U (da)
CS156812B1 (da)
CS155591B1 (da)
CS155580B1 (da)
CS154827B1 (da)
CS154090B1 (da)
CS153302B1 (da)
JPS499705U (da)
CH576454A5 (da)
CH587342A5 (da)
CH570031A5 (da)
CH571135A5 (da)
CH571478A5 (da)
CH574755A5 (da)
CH575813A5 (da)
CH568041A5 (da)
CH576796A5 (da)